Hemas Pharmaceuticals Now Certified for
‘Good Distribution Practices’ by Bureau Veritas

Hemas Pharmaceuticals, which has long been in the forefront of
ensuring that the people of the country have access to the highest quality products, has now been
recognized by Bureau Veritas as a Good Distribution Practices (GDP) organization, marking yet
another milestone.
GDP accreditation shows that Hemas Pharmaceuticals follows the World Health Organisation’s
requirements for Good Distribution Practices of Pharmaceutical Products. Furthermore, this
accreditation assures that quality management systems are consistent throughout the supply
chain. Bureau Veritas is a prominent certification body that supports organisations all over the
world to enhance their performance.
Commenting on the recognition, Jude Fernando, Managing Director, Hemas Pharmaceuticals and
Hemas Surgicals & Diagnostics stated: “I strongly believe that with this latest addition of
accomplishment, we can aim to address the diverse and sophisticated needs of all our partners as
every procedure follows international quality standards established for receiving, storing, and
distributing pharmaceuticals. As the number one Sri Lankan pharmaceutical importer and
distributor, now we are honoured to serve our principals with both the accolades of ISO
9001:2015 and GDP certification from Bureau Veritas, which is globally recognized and clearly
demonstrates the Hemas Pharmaceuticals commitment on compliance and quality”.
“We would like to congratulate Hemas Pharmaceuticals on being certified to the GDP
international standard. Being GDP certified will not only support the organization’s continued
growth but will also demonstrate the social responsibility in all aspects of the supply chain and the
commitment to responsible business practices. We take great pride in this association and look
forward to taking this partnership forward and achieving more challenging objectives in its
journey towards benchmarking best international practices in management systems”, added Shan
Nanayakkara, Country General Manager of Bureau Veritas
A fully owned subsidiary of Hemas Holdings PLC, Hemas Pharmaceuticals’ persistence and skill for
innovation has made it one of the most streamlined and modernised organisations in the nation’s
industry, with unrivalled sales and distribution operations. Designed to be ultra-efficient and
geared towards providing business partners with the solutions they need, Hemas Pharmaceuticals
currently holds over 30% of the market share as Sri Lanka’s largest pharmaceutical distributor.

Leave a Reply

Your email address will not be published. Required fields are marked *